Showing results (851-860 of 862) with videos related to
Sort By:
Pageof 87
The Journal of Clinical Investigation|December 15, 2023
ADORA2A-driven proline synthesis triggers epigenetic reprogramming in neuroendocrine prostate and lung cancersNa Jing, Kai Zhang, Xinyu Chen, et al.Cell Reports|October 10, 2024
SSRI antidepressant citalopram reverses the Warburg effect to inhibit hepatocellular carcinoma by directly targeting GLUT1Fangyuan Dong, Kang He, Shan Zhang, et al.Nature Cancer|May 27, 2022
Gremlin1 is a therapeutically targetable FGFR1 ligand that regulates lineage plasticity and castration resistance in prostate cancerChaping Cheng, Jinming Wang, Penghui Xu, et al.Epigenomics|September 3, 2024
The third symposium on treatment-induced neuroendocrine prostate cancer: insights and future directionsYuzhuo Wang, Joshua Scurll, Itzel Astiazarán Rascón, et al.Nature Communications|July 14, 2025
OsCDPK24 and OsCDPK28 phosphorylate heat shock factor OsHSFA4d to orchestrate abiotic and biotic stress responses in riceYu Fang, Haicheng Liao, Yingjie Wei, et al.Cancer Discovery|December 19, 2025
Serotonin modulates lineage plasticity in neuroendocrine prostate cancer via epigenetic reprogrammingYiyi Ji, Cheng-Wei Ju, Lei Chen, et al.Nature Cancer|March 18, 2025
A Gremlin 1-expressing splenic niche cell population restrains chronic myeloid leukemia by antagonizing the BMP pathwayJinming Wang, Penghui Xu, Zhongzhong Ji, et al.Cancer Letters|August 22, 2025
A multicenter, real-world study analysis: pembrolizumab changes treatment strategy for the patient with recurrent/metastatic head and neck squamous cell carcinomaMan Hu, Xia Li, Hong Feng, et al.Neuron|May 8, 2026
A peritumoral microenvironment engaged by Reg-EXTL3 axis fosters nerve-cancer interactions in pancreatic ductal adenocarcinomaShan Zhang, Fang-Yuan Dong, Shuqi Cai, et al.Nature|December 23, 2024
Steering perovskite precursor solutions for multijunction photovoltaicsShuaifeng Hu, Junke Wang, Pei Zhao, et al.Pageof 87